Dexcom gets rapid review status for glucose monitor:
This article was originally published in Clinica
Executive Summary
DexCom says that its US premarket approval (PMA) application for its short-term continuous glucose sensor, submitted in March 2005, has been accepted as filed and granted expedited review status by the FDA. The San Diego, California firm is developing continuous glucose monitoring systems for people with diabetes. Clinica FILED 1 June 2005 COPYRIGHT T&F Informa UK Ltd 2005